Work

Addressing Uneven Treatment Discontinuation Rate in the Chemotherapy Arm of the EV-302 Phase 3 Randomized Clinical Trial: Implications for Outcome Interpretation

Year: 2025

Type: article

Source: Clinical Genitourinary Cancer

DOI: 10.1016/j.clgc.2025.102423

Authors: Daniele Robesti, Filippo Micheli, Shesh N. Rai, Giuseppe Fallara, Andrea Gallina, Francesco Montorsi, Alberto Briganti, Nicola Fossati, Petros Grivas, Antoine G. van der Heijden, Guillaume Ploussard, Bernard Malavaud, Alberto Martini

Institutions: Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele, Ente Ospedaliero Cantonale, Università della Svizzera italiana, University of Cincinnati, Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo, University of Washington, Fred Hutch Cancer Center, Radboud University Medical Center, Institut universitaire du cancer de Toulouse Oncopole

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4413770735

FWCI: 2.513

Cites: 24

Cited by: 3

Related to: 10